Literature DB >> 24962609

The effect of hemin-induced oxidative stress on erythropoietin production in HepG2 cells.

Kazuhiko Nishimura1, Masahiro Tokida, Hideaki Katsuyama, Hiroshi Nakagawa, Saburo Matsuo.   

Abstract

Erythropoietin (EPO) and iron are both indispensable hematopoietic factors and are often studied in humans and rodents. Iron activates prolyl hydroxylases (PHDs) and promotes the degradation of the α-subunit of hypoxia inducible factor (HIF), which regulates EPO production. Iron also causes oxidative stress. Oxidative stress leads to alterations in the levels of multiple factors that regulate HIF and EPO production. It is thought that iron influences EPO production by altering two pathways, namely PHDs activity and oxidative stress. We studied the differential effect of varying concentrations of hemin, an iron-containing porphyrin, on EPO production in HepG2 cells. Hemin at 100 µM reduced EPO mRNA expression. The hemin-induced reduction of EPO mRNA levels was attenuated at concentrations greater than 200 µM and EPO production increased in the presence of 500 µM hemin. In comparison, protoporphyrin IX, iron-free hemin did not influence EPO mRNA expression. Additionally, malondialdehyde (MDA) concentrations and superoxide dismutase (SOD) activity significantly increased with 300 µM hemin. Importantly, the antioxidant tempol inhibited the hemin-induced (500 µM) increase in EPO mRNA levels. In conclusion, these results suggest that restraint of EPO production by hemin was offset by the promotion of EPO production by hemin-induced oxidative stress at hemin concentrations greater than 300 µM.
© 2014 International Federation for Cell Biology.

Entities:  

Keywords:  erythropoietin production; iron; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24962609     DOI: 10.1002/cbin.10329

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

Review 1.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

Review 2.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

3.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

4.  Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats.

Authors:  Ho-Shan Niu; Chin-Hong Chang; Chiang-Shan Niu; Juei-Tang Cheng; Kung-Shing Lee
Journal:  Drug Des Devel Ther       Date:  2016-06-03       Impact factor: 4.162

5.  Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death.

Authors:  Min-Young Kwon; Eunhee Park; Seon-Jin Lee; Su Wol Chung
Journal:  Oncotarget       Date:  2015-09-15

6.  Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage.

Authors:  Juan Song; Yong Wang; Falin Xu; Huiqing Sun; Xiaoli Zhang; Lei Xia; Shan Zhang; Kenan Li; Xirui Peng; Bingbing Li; Yaodong Zhang; Wenqing Kang; Xiaoyang Wang; Changlian Zhu
Journal:  CNS Drugs       Date:  2021-05-06       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.